10x Genomics, Inc. (TXG) Total liabilities 2018–2025
10x Genomics, Inc. (TXG) total liabilities at each fiscal year-end, per SEC filings.
$245.0MFY2025 · since FY2018: $101.1M → $245.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $245.0M | +17.5% |
| FY2024 | $208.5M | -7.0% |
| FY2023 | $224.1M | +0.4% |
| FY2022 | $223.2M | +10.9% |
| FY2021 | $201.3M | +5.8% |
| FY2020 | $190.3M | +2.4% |
| FY2019 | $185.8M | +83.9% |
| FY2018 | $101.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice